-transparent.png){kind=logo}
Serum concentrations and pharmacokinetic parameters of ofloxacin were measured in 10 patients on haemodialysis treatment. Serum half-life during the interdialytic interval was 48 hours, and during haemodialysis treatment 10 hours. The decrease in serum concentrations during a 4-hour haemodialysis was 25%. After several doses of ofloxacin, saturation of the tissues and a rediffusion of ofloxacin from the tissues during haemodialysis has to be assumed. This equalizes the rate of elimination, and the serum ofloxacin concentration did not change during the last 2 hours of haemodialysis. The negative influence of phosphate binders on the resorption of ofloxacin can be confirmed. The following ofloxacin dosage regimen is recommended in haemodialysis patients: 200 mg initially, 100 mg loading dose after the first haemodialysis, then 100 mg daily.
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
November 1990,
The Journal of antimicrobial chemotherapy,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
September 1988,
The Journal of antimicrobial chemotherapy,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
January 1992,
European journal of clinical pharmacology,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
August 1991,
Antimicrobial agents and chemotherapy,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
December 1987,
Clinical nephrology,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
July 1989,
Journal of chemotherapy (Florence, Italy),
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
June 2002,
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
March 1999,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
November 1996,
The Journal of antimicrobial chemotherapy,
A Dörfler, and
W Schulz, and
F Burkhardt, and
M Zichner
January 1987,
Drugs,
